ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thomas J Birdas
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Birdas, T. J
Right arrow Search for Related Content
PubMed
Right arrow Articles by Birdas, T. J
Related Collections
Right arrow Lung - cancer
Right arrowRelated Article

Ann Thorac Surg 2005;79:384
© 2005 The Society of Thoracic Surgeons


Correspondence

Effects of Pneumonectomy on Survival of Patients With Stage I Lung Cancer

Thomas J. Birdas, MD

Allegheny General Hospital, Department of Cardiothoracic Surgery, 320 E North Ave, South Tower, 14th Floor, Pittsburgh, PA 15212, USA

tbirdas1{at}aol.com

To the Editor:

In their article on the outcomes of pneumonectomy for stage I nonsmall cell lung cancer, Alexiou and colleagues [1] conclude that "pneumonectomy for stage T1N0 or T2N0 nonsmall cell lung cancer has a potent, adverse impact on survival." Indeed this is a very interesting finding.

As the authors point out in the "Discussion" section, lack of information on disease recurrence and cause of death do not allow for more specific conclusions and generation of hypotheses regarding the reasons for the decreased survival in the pneumonectomy group.

Another interesting question is whether early or late survival rates are equally affected, particularly because the pneumonectomy patients experienced significantly higher perioperative mortality rates. Here the authors comment that "the survival difference continues to increase over the first 2 or 3 postoperative years [1]." However this is not evident from the data presented; in fact all three survival curves shown have overlapping 95% confidence intervals at 3 and 5 years. Perhaps an alternative way of presenting the data would be the use of hazard function analysis [2] or even simply excluding the perioperative deaths. Although the significance of the findings on overall mortality should not be underestimated, separating early and late components of the mortality risk is very important in our decision making and care of these patients.

References

  1. Alexiou C, et al. Pneumonectomy for stage I (T1N0, and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival. Ann Thorac Surg. 2003;76:1023–1028[Abstract/Free Full Text]
  2. Blackstone EH. Outcome analysis using hazard function methodology. Ann Thorac Surg. 1996;61(Suppl 2):S2–7; discussion S33–4

Related Article

Reply
Christos Alexiou, David Beggs, George Doukas, Kostas Kotidis, Ellis Morgan, and Gaetano Rocco
Ann. Thorac. Surg. 2005 79: 384-385. [Extract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thomas J Birdas
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Birdas, T. J
Right arrow Search for Related Content
PubMed
Right arrow Articles by Birdas, T. J
Related Collections
Right arrow Lung - cancer
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS